Pluristem Therapeutics (PSTI) Strengthens Executive Team; Announces Senior Executive Appointments
2/5/2014 9:42:18 AM
HAIFA, Israel, Feb. 5, 2014 (GLOBE NEWSWIRE) -- Pluristem Therapeutics, Inc. (Nasdaq:PSTI) (TASE:PLTR), a leading developer of placenta-based cell therapies, today announced the appointments of two of its senior executives. These executive appointments support the Company's growth and opportunities both on the clinical development front and with its big-pharma corporate partnerships. This comes at a time when Pluristem is advancing its cell therapies for numerous indications through global clinical trials.
Help employers find you! Check out all the jobs and post your resume.
comments powered by